Monitoring testosterone replacement therapy - a strategy for distinguishing real and falsely high concentrations of testosterone.

Monitoring testosterone replacement therapy - a strategy for distinguishing real and falsely high concentrations of testosterone. - Study on the detection of falsely high testosterone concentrations

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51953

Enrollment

Registered

2022-12-12

Start date

2023-05-04

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genderdysforie genderdysphoria genderincongruence

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Status after gonadectomy, use of testosterone gel 40.5/50mg-100, usual time of administration of testosterone gel inthe morning, appointment time at the outpatient clinic between 8:30 and 12:00, need for the measurement of thetestosterone concentration in the blood in the context of patient care

Exclusion criteria

Exclusion criteria: Use of estrogens

Design outcomes

Primary

Measure	Time frame
testosterone and estradiol concentration in the blood	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results